Meruvax II is a vaccine that provides protection against the measles virus. Measles is a highly contagious viral infection that can lead to serious complications, especially in young children and individuals with weakened immune systems. The Meruvax II vaccine contains live attenuated measles virus that stimulates the body’s immune system to produce antibodies against the virus.

It is recommended that children receive two doses of the Meruvax II vaccine, with the first dose given at 12-15 months of age and the second dose given at 4-6 years of age. Adults who have not been vaccinated or do not have evidence of immunity to measles should also receive the vaccine.

Common side effects of the Meruvax II vaccine may include mild fever, rash, and soreness at the injection site. Serious side effects are rare but can include allergic reactions. It is important to discuss any concerns or medical conditions with your healthcare provider before receiving the vaccine.

By getting vaccinated with Meruvax II, you are not only protecting yourself from measles but also helping to prevent the spread of the virus to others in your community. Measles outbreaks can occur when vaccination rates are low, so it is important to ensure that you and your loved ones are up to date on all recommended vaccines.

If you have any questions about the Meruvax II vaccine or would like to schedule a vaccination appointment, please contact your healthcare provider. Stay proactive about your health and protect yourself and those around you from preventable diseases like measles.